Cell cycle regulatory proteins in glomerular disease

Kidney International

Volumn 56, Issue 4, 1999, Pages 1208-1215

  Siiankland, Stuart J ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cell proliferation; Glomerular growth; Hypertrophy; Progressive glomerulosclerosis

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; REGULATOR PROTEIN;

ANIMAL CELL; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONFERENCE PAPER; DIABETIC NEPHROPATHY; GLOMERULOPATHY; KIDNEY DEVELOPMENT; KIDNEY DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032820678     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00709.x     Document Type: Conference Paper

References (57)

1. FARDEE AB: G1 events and regulation of cell proliferation. Science 246:603-608, 1989
2. PABST R, STERZEL RB: Cell renewal of glomerular cell types in normal rats. An autoradiosraphic analysis. Kidney lut 24:626-631, 19S3
3. PREISIG PA, FRANCII HA: Renal epithelial hyperplasia and hypertrophy. Seinin Nephrol 15:327-340, 1995
4. MEIKRANTZ W, SCIIEGAL R: Apoptosis and the cell cycle. J Cell Biochem 58:160-174, 1995
5. GAO CY, ZELENKA PS: Cyclins, cyclin-dependent kinases and differentiation. Bioessays 19:307-315, 1997
6. SIIERR CJ: Mammalian Gl cyclins. Cell 73:1059-1065, 1993
7. SIIANKLAND SJ: Cell cycle control and renal disease. Kidney lut 52:294-308, 1997
8. SIIERR CJ, ROBERTS JM: Inhibitors of mammalian Gl cyclin-dependent kinases. Genes Dev 9:1149-1163, 1995
9. JOHNSON RJ: The glomerular response to injury: Progression or resolution? Kidney bit 45:1769-1782, 1994
10. KLAHR S, SCHREINER G, ICHIKAWA I: Progression in renal disease. N EnSU Med 318:1657-1666, 1988
11. PESCE CM, STRIKER LJ, PETEN E, ELLIOT SJ, STRIKER GE: Glomerulosclerosis at both early and late stages is associated with increased cell turnover in mice transgenic for growth hormone. Lab Invest 65:601-605, 1991
12. FUKUI MNT, EBIHARA I, NAGAOKA I, TOMINO Y: Low-protein diet attenuates increased gene expression of platelet-derived growth factor and transforming growth faclor-β in experimental glomerular sclerosis. J Lab Clin Med 121:224-234, 1992
13. FLOEGE J, JOHNSON RJ, GORDON KL, IIDA H, PRITZL P, YOSHIMURA A, CAMPBELL C, ALPERS CE, COUSER WG: Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney hit 40:477-488, 1991
14. BRANDT J, PIPPIN J, SCHULZE M, MANSCH GM, ALPERS CE, JOHNSON RJ, GORDON K, COUSER WG: Role of complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephrilis. Kidney bit 49:335-343, 1996
15. JOHNSON RJ, RAINES EW, FLOEGE J, YOSHIMURA A, PRITZL P, ALPERS CE, Ross R: Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 175:1413-1416, 1993
16. FLOEGE J, ENG E, YOUNG B A, COUSER WG, JOHNSON RJ: Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 43:369-380, 1993
17. GESUALDO L, Di PAOLO S, RANIERI E, SCIIENA FP: Trapidil inhibits human mesangial cell proliferation: Effect on PDGF B-receptor binding and expression. Kidney bit 46:1002-1009, 1994
18. TSUBOI Y, SIIANKLAND SJ, GRANDE JP, WALKER HJ, JOHNSON RJ, DOUSA TP: Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV. J Clin Invest 98:262-270, 1996
19. YAMAMOTO T, WISON CB: Complement dependence of antibodyinduced mesangial cell injury in the rat. J bnmunol 138:3758-3765, 1987
20. YAMAMOTO T, WILSON CB: Quantitative and qualitative studies of antibody-induced mesangial cell damage in the rat. Kidney bit 32:514-525, 1987
21. SIIANKLAND SJ, HUGO C, COATS SR, NANGAKU M, PICHLER RH, GORDON KL, PIPPIN J, ROBERTS JM, COUSER WG, JOHNSON RJ: Changes in cell cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney bit 50:1230-1239, 1996
22. GIRARD F, STRAUSFELD U, FERNANDEZ A, LAMB N: Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67:1169-1179, 1991
23. JEFFREY PD, Russo A A, POLYAK K, GIBBS E, HURWTTZ J, MASSAGUE J, PAVLETICII NP: Mechanism of CDK activation revealed by the structure of a cyclin A-CDK2 complex. Nature 376:313-320,1995
24. SIIANKLAND SJ, HAMEL PA, SCHOLEY JW: Cyclin and cyclin dependent kinase expression in the remnant glomerulus. J Am Soc Nephrol 8:368-375, 1996
25. SCIIOECKLMANN HO, RUPPRECIIT HD, ZAUNER I, STERZEL RB:
26. TGF-βl induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-CDK2 activation and retinoblastoma protein phosphorylation. Kidney bit 51:1228-1236, 1996
27. PIPPIN JW, Qu Q, MEIJER L, SIIANKLAND SJ: Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with roscovitine, a novel cyclindependent kinase antagonist. J din Invest 100:2512-2520, 1997
28. MEIJER L: Chemical inhibitors of cyclin-dependent kinases. Trends Cell Biol 6:393-397, 1996
29. MEIJER L, BORGNE A, MULNER O, CIIONG JPJ, BLOW JJ, INAGAKI N, INAGAKI M, DELCROS J, MOULINOUX JP: Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclindependent kinases cdc2, cdk2 and cdk5. Enr J Biodiem 243:527536, 1996
30. DE AZEVEDO WF, LECLERC S, MEIJER L, HAVLICEK L, STRNAD M, KIM S-H: Inhibition of cyclin-dependent kinases by purine analogues: Crystal structure of human cdk2 complexed with roscovitine. Eur J Biochem 243:518-526, 1997
31. ELLEDGE SJ, HARPER JW: CDK inhibitors: On the threshold of checkpoints and development. CitrrOpin Cell Biol 6:847-852,1994
32. ELLEDGE SJ: Cell cycle checkpoints: Preventing an identity crisis. Science 274:1664-1672, 1996
33. SlIANKLAND SJ, PlPPlN J, FLANAGAN M, COATS SR, NANGAKU M, GORDON KL, ROBERTS JM, COUSER WG, JOHNSON RJ: Mesangial cell proliferation mediated by PDGF and bFGF is determined by levels of the cyclin kinase inhibitor p27Kipl. Kidney Int 51:10881099, 1997
34. Kip1 safeguards against inflammatory injury. Nature Med 4:575-580, 1998
35. KRIZ W: Progressive renal failure-inability of podocytes to replicate and the consequences for development of glomerulosclerosis. Nephrol Dial Transplant 11:1738-1742, 1996
36. SAXEN L: Organogenesis of the Kidney. Cambridge, Cambridge University Press, 1987
37. kip1, in developing and mature human kidney. Kidney Int 53:892-896, 1998
38. ZIIANG P, LIEGEOIS NJ, WONG C, FINEGOLD M, Hou H, THOMPSON JC, SILVERMAN A, HARPER JW, DEPINHO RA, ELLEDGE SJ: Altered cell differentiation and proliferation in mice lacking p57Kip2 indicates a role in Beckwith-Wiedermann syndrome. Nature 387:151158, 1997
39. NAGATA M, YAMAGUCHI Y, KOMATSU Y, ITO K: Mitosis and the presence of binucleate cells among glomerular podocytes in diseased human kidneys. Nepliron 70:68-71, 1995
40. KRIZ W, ELGER M, NAGATA M, KRETZLER M, UIKER S, KOEPPENHAGEMANN I, TENSCHERT S, LEMLEY K: The role of podocytes in the development of glomerular sclerosis. Kidney Int 45(Suppl 42):S64-S72, 1994
41. KIHARA I, YATOITA E, KAWASAKI K, YAMAMOTO T: Limitations of podocyte adaptation for glomerular injury in puromycin aminonucleoside nephrosis. Patlwl Int 45:625-634, 1995
42. SALANT DJ, DARBY C, COUSER WG: Experimental membranous glomerulonephrilis in rats. J Clin Invest 66:71-81, 1980
43. CYBULSKY AV, RENNKE HG, FEINTZEIG ID, SALANT DJ: Complement-induced glomerular epithelial cell injury: Role of membrane attack complex in rat membranous nephropathy. J Clin Invest 77:1096-1107, 19S6
44. KRIZ W, HAHNEL B, ROSENER S, ELOER M: Long-term treatment of rats with FGF-2 results in focal segmentai glomerulosclerosis. Kidney Int 48:1435-1450, 1995
45. RENNKE HG: How does glomerular epithelial cell injury contribute to progressive glomerular damage? Kidney Int 45(Suppl):S58-S63, 1994
46. SlIANKLAND SJ, FLOEGE J, TlIOMAS SE, NANGAKU M, HUGO C, PIPPIN J, HENNE K, HOCKENBERRY DM, JOHNSON RJ, COUSER WG: Cyclin kinase inhibitors are increased during experimental membranous nephropathy: Potential role in limiting glomerular epithelial cell proliferation in vivo. Kidney Int 52:404-413, 1997
47. ADLER S, CHEN X, ENG B: Control of rat glomerular epithelial cell growth in vitro. Kidney Int 37:1048-1054, 1990
48. FLOEGE J, KRIZ W, SCHULZE M, SUSANI M, KERJASCHKI D, MOONEY A, COUSER WG, Kocn KM: Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephrology. J Clin Invest 96:2809-2819,1996
49. RABKIN R, FERVENZA FC: Renal hypertrophy and kidney disease in diabetes. Diabetes Metab Rev 12:217-241, 1996
50. SEYER-HANSEN K: Renal hypertrophy in experimental diabetes mellitus. Kidney Int 23:643-646, 1983
51. MAUER SM: Structural-functional correlations of diabetic nephropathy. Kidney Int 45:612-622, 1994
52. PAGTALUNAN ME, MILLER PL, JUMPING-EAGLES, NELSON RG, MYERS BD, RENNKE HG, COPLON NS, SUN L, MEYER TW: Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 99:342-348, 1997
53. FINE L: The biology of renal hypertrophy. Kidney Int 29:619-634, 1986
54. WAF1,CIP1 is increased in experimental diabetic nephropathy: Potential role in glomerular hypertrophy. J Am Sac Neplirol 9:986993, 1998
55. SHANKLAND SJ, HAMEL PA, ScuoLEY JW: Cyclin and cyclin-dependent kinase expression in the remnant glomerulus. J Am Soc Neplirol 8:368-375, 1997
56. WOLF G, SCHROEDER R, ZIYADEH FN, THAISS F, ZAIINER G, STAHL RAK: High glucose stimulates expression of p27Kipl in cultured mouse mesangial cells: Relationship to hypertrophy. Am J Pliysiol 42:F348-F56, 1997
57. WOLF G, SCHROEDER R, THAISS F, ZIYADEH FN, HELMCHEN U, STAHL RAK: Glomerular expression of p27Kipl in diabetic db/db mouse: Role of hyperglycemia. Kidney Int 53:869-879, 1998